ABIN251324

antibody from antibodies-online

Targeting: CYP17A1 CPT7, CYP17, P450C17, S17AH

Western blot (Supportive data in Antibodypedia)

ELISA (Recommended by provider)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

ABIN251324

Provider

antibodies-online

Product name

anti-Cytochrome P450, Family 17, Subfamily A, Polypeptide 1 (CYP17A1) antibody

Antibody type

Polyclonal

Description

Immunogen affinity purified

Reactivity

Human

Host

Goat

Vial size

0.1 mg

Storage

Store at -20°C. Avoid freeze-thaw cycles.

Handling

Avoid freeze-thaw cycles

References

Submitted references

Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.

Efstathiou E, Titus M, Wen S, Hoang A, Karlou M, Ashe R, Tu SM, Aparicio A, Troncoso P, Mohler J, Logothetis CJ
European urology 2015 Jan;67(1):53-60

---

Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone.

Efstathiou E, Titus M, Tsavachidou D, Tzelepi V, Wen S, Hoang A, Molina A, Chieffo N, Smith LA, Karlou M, Troncoso P, Logothetis CJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Feb 20;30(6):637-43

---

CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients.

Ohnishi T, Ogawa Y, Saibara T, Nishioka A, Kariya S, Fukumoto M, Onishi S, Yoshida S
Oncology reports 2005 Mar;13(3):485-9

Western blot

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

WB

Immunohistochemistry

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

IHC